Helena Katrina Tayton-martin - Net Worth and Insider Trading

Helena Katrina Tayton-martin Net Worth

The estimated net worth of Helena Katrina Tayton-martin is at least $0 dollars as of 2024-11-13. Helena Katrina Tayton-martin is the Chief Business Officer of Adaptimmune Therapeutics PLC and owns about 0 shares of Adaptimmune Therapeutics PLC (ADAP) stock worth over $0. Details can be seen in Helena Katrina Tayton-martin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Helena Katrina Tayton-martin has not made any transactions after 2020-08-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Helena Katrina Tayton-martin

To

Helena Katrina Tayton-martin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Helena Katrina Tayton-martin owns 1 companies in total, including Adaptimmune Therapeutics PLC (ADAP) .

Click here to see the complete history of Helena Katrina Tayton-martin’s form 4 insider trades.

Insider Ownership Summary of Helena Katrina Tayton-martin

Ticker Comapny Transaction Date Type of Owner
ADAP Adaptimmune Therapeutics PLC 2020-08-03 Chief Operating Officer

Helena Katrina Tayton-martin Latest Holdings Summary

Helena Katrina Tayton-martin currently owns a total of 1 stock. Helena Katrina Tayton-martin owns 0 shares of Adaptimmune Therapeutics PLC (ADAP) as of August 3, 2020, with a value of $0.

Latest Holdings of Helena Katrina Tayton-martin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADAP Adaptimmune Therapeutics PLC 2020-08-03 0 0.79 0

Holding Weightings of Helena Katrina Tayton-martin


Helena Katrina Tayton-martin Form 4 Trading Tracker

According to the SEC Form 4 filings, Helena Katrina Tayton-martin has made a total of 2 transactions in Adaptimmune Therapeutics PLC (ADAP) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Adaptimmune Therapeutics PLC is the sale of 200,000 shares on August 3, 2020, which brought Helena Katrina Tayton-martin around $2 Million.

Insider Trading History of Helena Katrina Tayton-martin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Helena Katrina Tayton-martin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Helena Katrina Tayton-martin Ownership Network

Ownership Network List of Helena Katrina Tayton-martin

No Data

Ownership Network Relation of Helena Katrina Tayton-martin

Insider Network Chart

Helena Katrina Tayton-martin Owned Company Details

What does Adaptimmune Therapeutics PLC do?

Who are the key executives at Adaptimmune Therapeutics PLC?

Helena Katrina Tayton-martin is the Chief Operating Officer of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .

Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary

Over the past 18 months, Helena Katrina Tayton-martin made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adaptimmune Therapeutics PLC Insider Transactions

No Available Data

Helena Katrina Tayton-martin Mailing Address

Above is the net worth, insider trading, and ownership report for Helena Katrina Tayton-martin. You might contact Helena Katrina Tayton-martin via mailing address: C/o Adaptimmune Therapeutics Plc, 60 Jubilee Ave, Milton Park, Abingdon, Oxfordshire X0 Ox14 4rx.